Impel Pharmaceuticals Inc.
IMPL · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $61 | $88 | $7 | $37 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $7 | $1 | $0 | $0 |
| Inventory | $8 | $3 | $0 | $0 |
| Other Curr. Assets | $3 | $2 | $1 | $3 |
| Total Curr. Assets | $80 | $95 | $8 | $40 |
| Property Plant & Equip (Net) | $7 | $3 | $4 | $3 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $0 | $0 | -$3 |
| Total NC Assets | $9 | $3 | $4 | $3 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $89 | $98 | $12 | $42 |
| Liabilities | – | – | – | – |
| Payables | $6 | $6 | $4 | $3 |
| Short-Term Debt | $2 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $3 | $0 |
| Other Curr. Liab. | $15 | $10 | $3 | $6 |
| Total Curr. Liab. | $22 | $16 | $11 | $8 |
| LT Debt | $50 | $29 | $8 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $61 | $0 | $127 | $0 |
| Total NC Liab. | $111 | $29 | $135 | $126 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $133 | $45 | $146 | $134 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $98 | $127 | $126 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$321 | -$215 | -$138 | -$92 |
| AOCI | $0 | -$98 | $0 | -$126 |
| Other Equity | $277 | $267 | -$122 | $252 |
| Total Equity | -$44 | $53 | -$134 | -$92 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $89 | $98 | $12 | $42 |
| Net Debt | -$9 | -$59 | $1 | -$37 |